Wealthspring Capital’s Translational Development Acquisition Corp Warrants TDACW Stock Holding History

Wealthspring Capital’s Portfolio TDACW Stock Details TDACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$144K	Sell	100,840 -1,505	-1%	-$1.51K	0.03%	119
2026 Q1	$12.3K	Sell	102,345 -1,270	-1%	-$291	﹤0.01%	191
2025 Q4	$29K	Hold	103,615	–	–	0.01%	171
2025 Q3	$30K	Sell	103,615 -1,385	-1%	-$375	0.01%	148
2025 Q2	$24.2K	Buy	+105,000	New	+$21.7K	0.01%	124

Wealthspring Capital's TDACW Position: Q2 2026 in Review

Wealthspring Capital reduced its Translational Development Acquisition Corp Warrants (TDACW) stake by 1.5% in Q2 2026, selling an estimated $1.51K and leaving 100,840 shares worth $144K. The position accounts for 0.03% of the portfolio, ranked #119.

Wealthspring Capital first reported a position in TDACW in Q2 2025 and has held it in 5 quarters since. 1 fund tracked by Wall St. Rank holds TDACW as of Q2 2026.

Wealthspring Capital held 100,840 shares of Translational Development Acquisition Corp Warrants worth $144K as of Q2 2026.
Wealthspring Capital sold 1,505 Translational Development Acquisition Corp Warrants shares in Q2 2026, an estimated $1.51K.
Translational Development Acquisition Corp Warrants made up 0.03% of Wealthspring Capital's portfolio in Q2 2026, its #119 holding.
Wealthspring Capital first reported a position in Translational Development Acquisition Corp Warrants in Q2 2025 and has held it in 5 quarters since.
1 fund tracked by Wall St. Rank held Translational Development Acquisition Corp Warrants as of Q2 2026.

Based on Wealthspring Capital's 13F filing for Q2 2026, filed 15 Jul 2026.